A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Haemonetics Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 7,826 shares of HAE stock, worth $575,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,826
Previous 43,573 82.04%
Holding current value
$575,132
Previous $3.6 Million 82.57%
% of portfolio
0.0%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.45 - $91.58 $2.59 Million - $3.27 Million
-35,747 Reduced 82.04%
7,826 $628,000
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $260,455 - $312,168
-3,206 Reduced 6.85%
43,573 $3.6 Million
Q1 2024

May 14, 2024

SELL
$71.24 - $85.35 $567,070 - $679,386
-7,960 Reduced 14.54%
46,779 $3.99 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $436,233 - $501,297
-5,413 Reduced 9.0%
54,739 $4.68 Million
Q3 2023

Nov 13, 2023

BUY
$82.56 - $93.49 $409,249 - $463,429
4,957 Added 8.98%
60,152 $5.39 Million
Q2 2023

Aug 11, 2023

SELL
$80.84 - $89.45 $520,124 - $575,521
-6,434 Reduced 10.44%
55,195 $4.7 Million
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $152,920 - $190,441
2,102 Added 3.53%
61,629 $5.1 Million
Q4 2022

Feb 13, 2023

SELL
$73.85 - $86.14 $1.58 Million - $1.85 Million
-21,454 Reduced 26.49%
59,527 $4.68 Million
Q3 2022

Nov 10, 2022

SELL
$63.3 - $78.66 $4,051 - $5,034
-64 Reduced 0.08%
80,981 $6 Million
Q2 2022

Aug 11, 2022

BUY
$49.27 - $66.08 $372,087 - $499,036
7,552 Added 10.28%
81,045 $5.28 Million
Q1 2022

May 13, 2022

BUY
$43.77 - $63.22 $766,762 - $1.11 Million
17,518 Added 31.3%
73,493 $4.65 Million
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $411,562 - $619,544
8,306 Added 17.42%
55,975 $2.97 Million
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $243,993 - $299,019
-4,236 Reduced 8.16%
47,669 $3.37 Million
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $2.69 Million - $6.15 Million
51,905 New
51,905 $3.46 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.